MedGen, Inc. (MDIN)
For informational purposes only. Not financial advice. Analysis by Sedat ANAK, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
MedGen, Inc. (MDIN) trades at $0.00 with AI Score 48/100 (Grade C). MedGen, Inc. operates an online health and wellness platform, connecting consumers with health information and professionals. Market cap: $90,309, Sector: Healthcare.
Price live · AI analysis from Mar 17, 2026Analyst Coverage for MDIN: MDIN does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates MDIN against Healthcare peers across nine fundamental dimensions and assigns an underweight signal based on the underlying data.
MDIN: the 1 perspectives are evenly split.
How is this calculated? →MedGen, Inc. (MDIN) Healthcare & Pipeline Overview
MedGen, Inc., based in Canada, operates an online health and wellness platform, connecting consumers with vital health information and professionals. The company faces competition in the digital health space and operates with a negative P/E ratio, reflecting its current stage of development and market capitalization.
What Is the Investment Thesis for MDIN?
MedGen, Inc. presents a high-risk, high-reward investment profile due to its early stage of development and presence in the competitive online health and wellness market. With a market capitalization of 90K and a negative P/E ratio of -600.00, the company's financial metrics indicate it is not yet profitable. The company's beta of 0.89 suggests it is less volatile than the market average. Growth catalysts include successful platform scaling, strategic partnerships with healthcare providers, and expansion into new service offerings. However, potential risks include intense competition, challenges in user acquisition, and the need for significant capital investment to achieve profitability. Investors should carefully consider the company's long-term growth potential and ability to execute its business plan in a rapidly evolving market.
Based on FMP financials and quantitative analysis
MDIN Key Highlights
- Reverse merger with 9430075 Canada Ltd. in June 2020, marking a strategic shift towards the online health and wellness platform model.
- Market capitalization of 90K indicates the company's small size and early stage of development.
- Negative P/E ratio of -600.00 reflects the company's current lack of profitability.
- Beta of 0.89 suggests the stock is less volatile than the overall market.
- Operates in the growing digital health market, which presents opportunities for expansion and innovation.
Who Are MDIN's Competitors?
MDIN is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | AI Score |
|---|---|---|---|---|
| ATAI Atai Beckley NV is a clinical-stage biopharmaceutical company focused on developing treatments for mental health disorders. The company | $4.88 | -5.97% | $1.80B | 68 |
| MEDS TRxADE HEALTH, Inc. | $7.59 | +4.55% | $13.28M | 63 |
| ONC BeOne Medicines Ltd. | $309.46 | +3.97% | $33.07B | 61 |
| NEUP Neuphoria Therapeutics Inc. | $3.44 | +1.78% | $18.59M | 60 |
| SDGCF Sundrug Co.,Ltd. | $30.97 | +9.90% | $3.62B | 48 |
| DCHPF Dechra Pharmaceuticals PLC | $46.90 | -0.21% | $5.34B | 48 |
| MYCOF Noveris Health Sciences Inc. | $2.00 | +0.00% | $117.10M | 48 |
| TSUSF Tsuruha Holdings Inc. | $17.25 | +0.00% | $4.20B | 49 |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are MDIN's Key Strengths?
- Online platform provides convenient access to health information and professionals.
- Reverse merger provided a strategic entry into the online health market.
- Potential for network effects as the platform grows.
- Operates in a growing digital health market.
What Are MDIN's Weaknesses?
- Small market capitalization and limited financial resources.
- Negative P/E ratio indicates lack of profitability.
- Intense competition in the online health market.
- Reliance on user acquisition and platform adoption.
What Could Drive MDIN Stock Higher?
- Expansion of the online health and wellness platform to attract more users.
- Potential partnerships with healthcare providers to broaden service offerings.
- Introduction of new features and functionalities on the platform to enhance user engagement.
What Are the Key Risks for MDIN?
- Intense competition in the online health market.
- Challenges in user acquisition and platform adoption.
- Need for significant capital investment to achieve profitability.
- Regulatory changes and compliance requirements.
- Data security and privacy concerns.
What Are the Growth Opportunities for MDIN?
- Expansion of Service Offerings: MedGen can expand its platform by incorporating additional health and wellness services, such as telemedicine consultations, personalized health plans, and remote monitoring solutions. The market for telemedicine is projected to reach $41.4 billion by 2026, presenting a significant growth opportunity for MedGen. Timeline: 1-2 years.
- Strategic Partnerships: Forming partnerships with healthcare providers, insurance companies, and employers can drive user acquisition and platform adoption. Collaborations with established healthcare networks can provide access to a broader customer base and enhance the platform's credibility. Timeline: Ongoing.
- Geographic Expansion: MedGen can expand its platform into new geographic markets, targeting regions with high internet penetration and a growing demand for online health solutions. International expansion can significantly increase the company's user base and revenue potential. Timeline: 2-3 years.
- Data Analytics and Personalization: Leveraging data analytics to personalize the user experience and provide targeted health recommendations can enhance user engagement and retention. By analyzing user data, MedGen can offer customized health plans and connect users with relevant health professionals. Timeline: Ongoing.
- Integration of AI and Machine Learning: Incorporating AI-powered tools and machine learning algorithms can improve the platform's functionality and efficiency. AI can be used to automate tasks, provide personalized health insights, and enhance the user experience. Timeline: 1-2 years.
What Opportunities Does MDIN Have?
- Expansion of service offerings to include telemedicine and personalized health plans.
- Strategic partnerships with healthcare providers and insurance companies.
- Geographic expansion into new markets.
- Leveraging data analytics to personalize the user experience.
What Threats Does MDIN Face?
- Regulatory changes and compliance requirements.
- Technological advancements and disruption.
- Data security and privacy concerns.
- Economic downturn and reduced consumer spending.
What Are MDIN's Competitive Advantages?
- Network effects: As more users join the platform, its value increases for both consumers and professionals.
- First-mover advantage: Being an early entrant in the online health and wellness market provides a competitive edge.
- Data assets: Accumulation of user data can be leveraged to personalize the user experience and improve the platform's functionality.
- Brand reputation: Building a trusted brand can attract and retain users.
What Does MDIN Do?
MedGen, Inc. was established in 2015 and significantly evolved through the acquisition of 9430075 Canada Ltd. on June 25, 2020, via a reverse merger. This strategic move positioned MedGen as an operator of an online health and wellness platform. The platform is designed to facilitate connections between consumers seeking health information and referrals and health and wellness professionals aiming to expand their client base. The company is headquartered in Winnipeg, Canada, and focuses on providing a digital space for health-related interactions. MedGen's core offering revolves around its online platform, which serves as a conduit for information dissemination and professional networking within the health and wellness sector. The platform aims to streamline the process by which individuals can access relevant health information and connect with qualified professionals. This approach addresses the growing demand for accessible and convenient healthcare solutions in the digital age. MedGen, Inc. operates within the competitive landscape of online health platforms, facing challenges related to user acquisition, platform development, and market penetration. The company's success hinges on its ability to differentiate its platform, attract both consumers and professionals, and establish a sustainable business model within the evolving digital health market.
What Products and Services Does MDIN Offer?
- Operates an online health and wellness platform.
- Connects consumers with health information and referrals.
- Facilitates connections between consumers and health and wellness professionals.
- Provides a digital space for health-related interactions.
- Aims to streamline access to health information.
- Offers a platform for professional networking within the health and wellness sector.
How Does MDIN Make Money?
- Generates revenue through subscriptions from health and wellness professionals.
- Potential for revenue through advertising and sponsored content.
- Possible future revenue streams from premium services and partnerships.
- Data analytics and insights for healthcare providers (potential).
What Industry Does MDIN Operate In?
MedGen, Inc. operates within the rapidly evolving digital health market. This market is characterized by increasing demand for online health and wellness solutions, driven by factors such as growing internet penetration, rising healthcare costs, and a shift towards preventative care. The competitive landscape includes established players and emerging startups, all vying for market share. MedGen's success depends on its ability to differentiate its platform, attract users, and establish strategic partnerships within the healthcare ecosystem. The industry is subject to regulatory changes and technological advancements, requiring companies to adapt and innovate to remain competitive.
Who Are MDIN's Key Customers?
- Consumers seeking health information and referrals.
- Health and wellness professionals looking to expand their client base.
- Healthcare providers seeking to connect with patients.
- Employers looking to provide wellness benefits to employees (potential).
MDIN Valuation & Market Position
With a 90K market cap, MedGen, Inc. sits in the micro-cap segment of the market. Relative to its peer group, MDIN's quantitative score of 48/100 is below the peer average of 60/100.
ROE 36%Key Financial Metrics
Return on equity for MedGen, Inc. stands at 36.3%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is 0.0%, showing how much profit it generates from its asset base. Its free cash flow yield is -0.0%, a gauge of the cash the business throws off relative to its market value. A current ratio of 0.00 means current liabilities exceed short-term assets, a liquidity point worth watching. Its earnings yield is -0.2%, the inverse of the P/E and a quick read on earnings relative to price.
MDIN Financials
Bull Case vs Bear Case
Bull Case
- Online platform provides convenient access to health information and professionals.
- Reverse merger provided a strategic entry into the online health market.
- Potential for network effects as the platform grows.
- Operates in a growing digital health market.
Bear Case
- Small market capitalization and limited financial resources.
- Negative P/E ratio indicates lack of profitability.
- Intense competition in the online health market.
- Reliance on user acquisition and platform adoption.
AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · July 2026
MDIN Latest News
No recent news available for MDIN.
MDIN Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for MDIN.
Price Targets
Wall Street price target analysis for MDIN.
MDIN MoonshotScore
What does this score mean?
The MoonshotScore rates MDIN's growth potential on a scale of 0-100 across multiple factors including innovation, market disruption, financial health, and momentum.
Leadership: Adir Iakya
CEO
Information on Adir Iakya's background is not available in the provided data. Without additional context, it is impossible to provide a detailed biography, including career history, education, and previous roles. Further research would be needed to complete this section.
Track Record: Due to the lack of information on Adir Iakya's background and specific achievements at MedGen, Inc., it is not possible to assess their track record. Key milestones and strategic decisions under their leadership cannot be evaluated without additional data.
MDIN OTC Market Information
The OTC Other tier represents the lowest tier of the OTC market, indicating that MedGen, Inc. may not meet the minimum financial standards required for higher tiers like OTCQX or OTCQB. Companies in this tier may have limited reporting requirements and may not be current in their disclosures. Investing in companies on the OTC Other tier carries significant risks due to the potential for limited information and regulatory oversight. These companies often have lower trading volumes and greater price volatility compared to those listed on major exchanges.
- OTC Tier: OTC Other
- Disclosure Status: Unknown
- Limited information and disclosure requirements on the OTC Other tier.
- Low trading volume and liquidity, leading to potential price volatility.
- Potential for lack of regulatory oversight and investor protection.
- Increased risk of fraud or manipulation.
- Difficulty in obtaining accurate and timely financial information.
- Verify the company's financial statements and disclosures.
- Research the company's management team and their track record.
- Assess the company's business model and competitive landscape.
- Evaluate the company's regulatory compliance and legal standing.
- Determine the company's capital structure and debt levels.
- Understand the risks associated with investing in OTC stocks.
- Consult with a financial advisor before making any investment decisions.
- Company is incorporated in Canada.
- Company has been in operation since 2015.
- Company operates an online platform, suggesting a modern business model.
- Reverse merger with 9430075 Canada Ltd. indicates a strategic effort to enter the online health market.
Common Questions About MDIN (Healthcare)
What does MedGen, Inc. do?
MedGen, Inc. operates an online health and wellness platform designed to connect consumers with vital health information and health and wellness professionals. Through its platform, MedGen aims to streamline the process by which individuals can access health-related resources and connect with qualified professionals. The company was formed through a reverse merger with 9430075 Canada Ltd. in 2020 and is based in Winnipeg, Canada. The platform is designed to facilitate health-related interactions in the digital space.
What do analysts say about MDIN stock?
There is no analyst coverage information available for MedGen, Inc. (MDIN) in the provided data. The company's market capitalization is $0.00B, and it has a negative P/E ratio of -600.00, indicating that it is not currently profitable. Investors should conduct their own due diligence and consider the company's financial metrics, growth potential, and risk factors before making any investment decisions. Due to its OTC listing, research resources may be limited.
What are the main risks for MDIN?
MedGen, Inc. faces several risks, including intense competition in the online health market, challenges in user acquisition and platform adoption, and the need for significant capital investment to achieve profitability. As an OTC-listed company, it also faces risks associated with limited information and disclosure requirements, low trading volume, and potential regulatory oversight. Data security and privacy concerns are also relevant risks given the nature of its business.
What are the key factors to evaluate for MDIN?
MedGen, Inc. (MDIN) holds an AI score of 48/100 (low). Not financial advice.
How frequently does MDIN data refresh on this page?
MDIN prices update in real time during U.S. market hours. Fundamentals refresh after quarterly filings; analyst ratings and AI insights update daily; news is aggregated continuously.
What has driven MDIN's recent stock price performance?
MedGen, Inc. (MDIN) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Online platform provides convenient access to health information and professionals. See the News tab for the latest drivers. Past performance does not predict future results.
Should investors consider MDIN overvalued or undervalued right now?
Valuing MedGen, Inc. (MDIN) requires multiple metrics. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.
What research should beginners do before buying MDIN?
Before investing in MedGen, Inc. (MDIN), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) what Wall Street analysts recommend and their price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- Information is based on limited data sources.
- OTC market investments carry higher risk.
- Financial metrics may not be up-to-date.